4//SEC Filing
Piekos Brian 4
Accession 0001415889-25-005611
CIK 0001348911other
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 8:35 PM ET
Size
6.1 KB
Accession
0001415889-25-005611
Insider Transaction Report
Form 4
Piekos Brian
Chief Financial Officer
Transactions
- Award
Restricted Stock Unit
2025-02-21+80,000→ 80,000 total→ Common Stock (80,000 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
- [F2]3/16th of the total number of shares underlying the RSUs shall vest on November 21, 2024 and 1/16 shall vest on each quarterly anniversary of the Vesting Commencement Date thereafter, for so long as grantee's Service (as defined in the Plan) does not terminate.
Documents
Issuer
KalVista Pharmaceuticals, Inc.
CIK 0001348911
Entity typeother
Related Parties
1- filerCIK 0001815308
Filing Metadata
- Form type
- 4
- Filed
- Feb 24, 7:00 PM ET
- Accepted
- Feb 25, 8:35 PM ET
- Size
- 6.1 KB